Early Feasibility Study to Assess Safety and Device Performance of AcoustiCare™
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03751904 |
|
Recruitment Status :
Withdrawn
(Sponsor is no longer pursuing the study.)
First Posted : November 23, 2018
Last Update Posted : January 29, 2019
|
Sponsor:
Signature Medical, Inc.
Information provided by (Responsible Party):
Signature Medical, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
AcoustiCareTM is a non-invasive clinical tool used for the detection of intracardiac pressures using heart sounds in patients with heart failure.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Heart Failure,Congestive | Device: AcoustiCare | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 0 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Other |
| Official Title: | Early Feasibility Study to Assess Safety and Device Performance of AcoustiCare™ |
| Actual Study Start Date : | January 25, 2019 |
| Estimated Primary Completion Date : | February 28, 2019 |
| Estimated Study Completion Date : | March 30, 2019 |
Resource links provided by the National Library of Medicine
MedlinePlus related topics:
Heart Failure
| Arm | Intervention/treatment |
|---|---|
|
AcoustiCare
Single Arm
|
Device: AcoustiCare
Electronic stethoscope |
Primary Outcome Measures :
- Incidence of Adverse Events [ Time Frame: Subjects will be assessed for adverse events through study completion, an average of 1 day ]The safety of the Acousticare device will be assessed by reviewing adverse events in all patients enrolled in the study
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Male or female subjects between the ages of 18 - 80 years
- Willing and able to sign informed consent form
- Normal subjects without a history of heart disease who are recruited from the surrounding community
- Subjects with heart failure undergoing treatment in a hospital setting
Exclusion Criteria:
- Hemodynamic instability (Systolic BP>180 or <90 and Diastolic BP>90 and <60)
- Acute coronary syndrome
- Prior heart transplant recipients
- Subjects who are pacemaker dependent
- Severe obesity (body mass index > 40 kg/m2)
- Subjects who are pregnant
No Contacts or Locations Provided
| Responsible Party: | Signature Medical, Inc. |
| ClinicalTrials.gov Identifier: | NCT03751904 |
| Other Study ID Numbers: |
SIG-0001 |
| First Posted: | November 23, 2018 Key Record Dates |
| Last Update Posted: | January 29, 2019 |
| Last Verified: | January 2019 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
Additional relevant MeSH terms:
|
Heart Failure Heart Diseases Cardiovascular Diseases |

